HS

Hocine Sidi-Said

Hocine is the Chairman of Celon Laboratories. He is a seasoned pharmaceutical and private equity executive with significant emerging markets experience spanning 30 years across big pharma, biopharmaceutical companies, and health care services. He has advised private equity firms and sovereign wealth funds or vehicles on healthcare strategy and investments. Hocine spent 17 years with Pfizer in senior management roles in Middle East, in Central and Eastern Europe and Asia. He has held Managing Directors’ positions in Indonesia, Denmark and India. He was also on the board of Glenmark Pharmaceuticals between 2009 and 2014. He is the founder of Bio-nAbler LLC, an alternative investment manager focused on life sciences.

Hocine has a Bachelor of Business Administration from the Schiller International University and has attended the Harvard Business School senior leadership programs in 1996 and 2001.